1
Clinical Trials associated with Monovalent Influenza Subvirion Vaccine, H7N7(NIAID)Evaluation of Priming by Pandemic Live Attenuated Influenza Vaccine (LAIV) on the Subsequent Response to Inactivated H7N7 Vaccine in Healthy Adults: A Non-Randomized, Open Label Study
H7N7 is one type of influenza virus that may pose a threat to humans if an outbreak occurs. This study will evaluate the safety and immune response to an H7N7 vaccine in people who have previously received a live attenuated influenza vaccine (LAIV) as part of a research study and people who have not previously received a LAIV.
100 Clinical Results associated with Monovalent Influenza Subvirion Vaccine, H7N7(NIAID)
100 Translational Medicine associated with Monovalent Influenza Subvirion Vaccine, H7N7(NIAID)
100 Patents (Medical) associated with Monovalent Influenza Subvirion Vaccine, H7N7(NIAID)
100 Deals associated with Monovalent Influenza Subvirion Vaccine, H7N7(NIAID)